CD8A and liver cancer: Through basic and effective cell experiments and biochemical characterization methods, it has been proved that the membrane proteins CD28 and MHC on the surface of autologous reinfused red blood cells can bind to CD8+T cells, thereby promoting the proliferation of CD8+T cells and inhibiting the malignant transformation of liver cancer.